COLUMN GROUP II, LP, Ten Percent Owner at Immune Design, holds 3.19M shares in RAPT Therapeutics (Ticker: RAPT), holds 3.57M shares in Oric Pharmaceuticals (Ticker: ORIC), holds 3.10M shares in Gritstone Oncology (Ticker: GRTS). Most recently, COLUMN GROUP II, LP Bought ― shares of RAPT Therapeutics on May 27, 2022 for an estimated value of 23.66K.